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Abstract
Introduction Portal vein embolization is an accepted method to increase the future remnant liver preoperatively. The aim of
this study was to assess the effect of preoperative portal vein embolization on liver volume and function 3 months after
major liver resection.
Materials and methods This is a retrospective case-control study. Data were collected of patients who underwent portal vein
embolization prior to (extended) right hemihepatectomy and of control patients who underwent the same type of resection
without prior portal vein embolization. Liver volumes were measured by computed tomography volumetry before portal
vein embolization, before liver resection, and 3 months after liver resection. Liver function was assessed by hepatobiliary
scintigraphy before and 3 months after liver resection.
Results Ten patients were included in the embolization group and 13 in the control group. Groups were comparable for
gender, age, and number of patients with a compromised liver. The mean future remnant liver volume was 33.0±8.0% prior
to portal vein embolization in the embolization group and 45.6±9.1% in the control group (p<0.01). Prior to surgery, there
were no significant differences in future remnant liver volume and function between the groups. Three months
postoperatively, the mean remnant liver volume was 81.9±8.9% of the initial total liver volume in the embolization group
and 79.4±11.0% in the control group (p>0.05). Remnant liver function increased up to 88.1±17.4% and 83.3±14%
respectively of the original total liver function (p>0.05).
Conclusion Preoperative portal vein embolization does not negatively influence postoperative liver regeneration assessed
3 months after major liver resection.
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Abbreviations
FRL Future remnant liver
FRLF Future remnant liver function
FRLV Future remnant liver volume
HBS Hepatobiliary scintigraphy
PVE Portal vein embolization
RLF Remnant liver function
RLV Remnant liver volume
TLF Total liver function
TLV Total liver volume
TV Tumor volume
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Portal vein embolization (PVE) has been widely accepted
as an effective means to increase the future remnant liver
volume (FRLV) in patients requiring extensive liver
resection. The safety and efficacy of PVE have been
confirmed by several studies and a recent meta-analysis.
1–4
PVE induces atrophy of the ipsilateral liver segments with
concomitant compensatory hypertrophy of the future
remnant liver (FRL). Preoperative PVE is recommended
when the FRLV is less than 30–40% of the total liver
volume (TLV) as determined by computed tomography
(CT) volumetry, depending on the presence of underlying
liver disease (e.g., steatosis, cholestasis).
5,6
Liver regeneration is generally assessed by CT
volumetry. Liver volume, however, does not necessarily
represent liver function during liver regeneration.
7,8 Liver
function can accurately be assessed by technetium-99m
mebrofenin hepatobiliary scintigraphy (
99mTc-mebrofenin
HBS).
7,9
The underlying mechanism of liver regeneration after
partial liver resection or PVE is not fully understood. One
suggested trigger for regeneration of the nonembolized liver
lobes after PVE or resection is the instant increase in portal
blood flow to the FRL.
10–12 When right PVE is performed,
the portal blood flow is preoperatively diverted to the left
liver lobes. As a consequence, minimal changes in portal
blood flow are induced at the time of partial liver resection
and therefore, this trigger for posthepatectomy liver
regeneration is lacking. Our hypothesis is therefore that
preoperative PVE might hamper postoperative liver regen-
eration. The aim of this study was to evaluate the effect of
preoperative PVE on postoperative liver volume and
function 3 months after major liver resection.
Materials and Methods
Patients
Eighteen patients underwent PVE of the right portal system
prior to (extended) right hemihepatectomy at our institution
between January 2005 and November 2007. Only those
patients in whom a complete set of CT scans was obtained
were included in the study, i.e., a four-phase CT scan prior
to PVE, 3–4 weeks after PVE (before liver resection), and
3 months after liver resection (n=10). In all the patients,
HBS was performed before PVE and in nine patients
3 months after liver resection.
Patients who had undergone (extended) right hemi-
hepatectomy without prior PVE in the same period and of
whom a CT scan had been obtained prior to and 3 months
after liver resection were included in the control group (n=
13). Twelve of the 13 patients underwent HBS prior to
PVE, which was repeated 3 months after liver resection in
11 patients. Patient characteristics, including gender, age,
and number of patients with a compromised liver were
compared for both groups.
Indications for surgery in the control group were
colorectal metastasis (n=5), hilar cholangiocarcinoma (n=
4), hepatocellular carcinoma (n=1), and other metastases
(n=3). In the PVE group, the indications were colorectal
metastasis (n=5), hilar cholangiocarcinoma (n=1), hepato-
cellular carcinoma (n=3), and neuroendocrine tumor (n=1).
Postoperative complications were subdivided into “minor”
(grades I and II) or “major” (grades III, IV, V) according to
the revised 2004 Clavien classification.
13
CT Volumetry
Liver volumes were measured using CT. The total liver, the
FRL, and tumor mass were manually delineated on each 5-
mm slide of the portal phase images. The TLV, tumor
volume (TV), and FRLV were calculated using dedicated
software (Mx-View 3.52, Philips Medical Systems, The
Netherlands; Fig. 1). The percentage FRLV before PVE
was calculated by:
14
%FRLVpre PVE ¼
FRLVpre PVE
TLV   TV ðÞ pre PVE
 !
  100%
To obtain the percentage, FRLV after PVE was comput-
ed by:
%FRLVpre op ¼
FRLVpre op
TLV   TV ðÞ pre PVE
 !
  100%
The remnant liver volume (RLV) 3 months after liver
resection was calculated as a percentage of the initial total
functional liver volume (TLV-TV):
%RLV3 months ¼
RLV
ðTLV   TVÞpre PVE
 !
  100%
Hepatobiliary Scintigraphy
HBS was performed using
99mTc-mebrofenin as previously
described.
7 Briefly, after injection of 85 MBq of
99mTc-
mebrofenin (Bridatec; GE-Amersham Health), dynamic
images were acquired with a γ-camera (Diacam, Siemens,
Milwaukee, WI, USA) for 60 min. During the first 10 min,
60 frames of 10 s were acquired (liver uptake phase)
followed by 50 frames of 1 min (liver excretion phase).
Total hepatic
99mTc-mebrofenin uptake rate was calculated
as described by Ekman et al.
15 On preoperative scan,
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the heart (serving as blood pool), and the total field of view.
From these ROIs, three time–activity curves were generat-
ed. The total hepatic
99mTc-mebrofenin uptake rate, repre-
senting total liver function (TLF), was calculated as percent
per minute (of the injected dose) based on these three
parameters. Calculations of the hepatic
99mTc-mebrofenin
uptake rate were performed using measured values obtained
between 150 and 350 s postinjection to ensure that hepatic
uptake calculations were performed during a phase of
homogenous distribution of the agent in the blood pool,
before occurrence of the rapid phase of hepatic excretion. To
compensate for differences in individual metabolic require-
ments, the TLF was divided by the body surface area and
expressed as percent per minute per square meter.
Portal Vein Embolization
PVE was performed in patients in whom the estimated
FRLV, based on CT volumetry, was <30% in case of
normal liver parenchyma and <40% in patients with
compromised liver parenchyma due to steatosis, cholesta-
sis, or fibrosis. PVE was performed using the ipsilateral
percutaneous transhepatic approach. After retrograde cathe-
terization via a peripheral portal branch (segment 6 or 7), the
right portal trunk and intrahepatic tributaries were occluded
using a combination of polyvinyl alcohol particles (300–
500 μm, Cook, Bloomington, IN, USA) and platinum coils of
various sizes (Tornado embolization microcoil, Cook).
Statistical Analysis
Statistical analysis was performed using Statistical Package
for Social Sciences (SPSS, Chicago, IL, USA). Continuous
variables were expressed as mean ± standard deviation
(SD). An independent sample t test was performed to assess
the difference in future remnant liver volume and function
between the two groups prior to surgery. A mixed analysis
of variance was conducted to assess whether there were
PVE and time differences in CT volumetry and HBS
outcomes between the two groups after liver surgery. The
correlation between variables was tested using the Pearson
correlation coefficient r. All tests were two-tailed and
differences were evaluated at the 5% level of significance.
Results
Patient characteristics are shown in Table 1. There were no
significant differences between the two groups with respect
to gender, age, and number of patients with a compromised
liver.
The FRLV was based on the actual removed part of the
liver. Prior to resection, the %FRLV was calculated taking
into account the maximum volume of liver that would need
to be resected to achieve complete removal of all lesions. In
some patients, the extent of the resection was less than
expected based on intraoperative findings, resulting in a
higher %FRLVpre-PVE.
The %FRLVpre-PVE was 33.0±8.0% in the PVE group
compared to a %FRLVpre-op 45.6±9.1% in the control
group (p=0.002). Three to 4 weeks (mean 23 days) after
PVE, the %FRLVpre-op increased to 41.6±9.5%, resulting in
no significant difference between the two groups prior to
liver resection (p=0.33). Liver scintigraphy showed a mean
99mTc-mebrofenin uptake rate in the total liver of 7.90±
1.5%/min/m
2 in the control group and 7.11±1.6%/min/m
2
in the PVE group before any intervention (p=0.24).
The increase in percentage remnant liver volume from
preoperatively to 3 months after major liver surgery was not
Figure 1 CT cross section of the liver showing total liver (yellow
delineation) and the future remnant liver (red delineation). CT
volumetry showed that the future remnant liver was markedly
increased 3 weeks after portal vein embolization (pre-op, 507 ml)
compared to before portal vein embolization (pre-PVE, 392 ml). Three
months after partial liver resection, the remnant liver volume almost
reached its original total liver volume. For interpretation of the
references to color in this figure legend, the reader is referred to the
online version of this article.
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after surgery, the mean RLV in the PVE group was 81.9±
8.9% of the initial total liver volume compared to 79.4±
11.0% in the control group (p=0.57; Table 1; Fig. 2). In
addition, the postoperative increase in liver function did not
differ between both groups (p=0.471). Three months
postoperatively, the RLF regained 88.1±17.4% of the
original total liver function in the PVE group compared to
83.3±14% in the control group (p=0.50; Fig. 3). No
correlation was found between liver volume and function
(r=0.13, p=0.59).
Discussion
The main goal of this study was to evaluate the influence of
PVE on volumetric and functional liver regeneration after
Figure 2 CT volumetry data. Mean percentage of (future) remnant liver
volume (FRLV) in relation with initial total functional liver volume.
Prior to PVE (pre-PVE), this percentage was significantly lower in the
group requiring PVE (**p<0.01). Three to 4 weeks after PVE (pre-op),
the FRLVincreased with 8.7% in the PVE group, leading to comparable
values in the two groups. Three months after partial liver resection (3 m
post-op), remnant liver volumes reached approximately 80% of initial
total functional liver volume in both groups.
Figure 3 Uptake of
99mTc-mebrofenin by the total liver prior to any
intervention and 3 months after partial liver resection. There were no
significant differences in uptake between the PVE and the control
groups at both time points. The remnant liver function reached 88.1%
and 83,3%, respectively, of the original total liver function in both
groups (p=0.50).
Table 1 Patient Characteristics of Patients Undergoing Liver Resection with (PVE Group) or Without (Control Group) Prior Portal Vein
Embolization
PVE group (n=10) Control group (n=13) p value
Female/male 6/4 8/5 n.s.
b
Mean age in years (range) 56.1 (49–74) 55 (39–71) n.s.
c
Compromised/noncompromised 6/4 7/6 n.s.
b
Standard/extended hemihepatectomy 5/5 10/3 n.s.
b
Postoperative complications (minor/major
a) 5 (3/2) 7 (4/3) n.s.
b
Mean ± SD %FRL volume before PVE 33.0±8.0 45.6±9.1 <0.01
c
Mean ± SD %FRL volume preoperative 41.7±9.5 45.6±9.1 n.s.
c
Mean ± SD %FRL 3 months after liver resection 81.9±8.9 79.4±11.0 n.s.
c
Mean ± SD FRL function before PVE 7.1±1.6 7.9±1.5 n.s.
c
Mean ± SD FRL function 3 months after liver resection 6.2±1.8 6.5±2.1 n.s.
c
Both groups were comparable for gender, age, number of patients with a compromised liver, postoperative complications, and preoperative future
remnant liver volume. Future remnant liver volume before PVE was significantly smaller in the PVE group than in the control group, which was
equalized 3–4 weeks after PVE. Three months after major liver resection, the remnant liver gained up to 80% of its initial total functional liver
volume in both groups
aAccording to the revised 2004 Clavien classification (7): minor = grades I and II; major = grades III and above
bPearson’s chi-square test
cIndependent sample T-test
J Gastrointest Surg (2009) 13:1464–1469 1467major liver resection. CT volumetry was performed prior to
PVE and surgery. The increase of the %FRLVafter PVE (%
FRLVpre-op−pre-PVE) was 8.7% in 23 days. In a recent meta-
analysis, a mean increase of 11.9% was reported 29 days
after PVE.
16 However, results between the various studies
are difficult to compare due to substantial differences in the
time interval between PVE and subsequent CT volumetry
and the different techniques of embolization. For example,
Farges et al. observed an increase in FRL of 16% 4–
8 weeks after PVE
17 whereas Elias et al. reported an
increase of 13% 1 month after PVE.
18 Ribero et al.
19 and
Madoff et al.
20 showed an increase of 8.8% and 7.7%, 2–
8a n d2 –4 weeks after PVE, respectively, using a
calculation based on body surface area.
Three months after partial liver resection, the remnant
liver volume regenerated to approximately 80% of its
original total volume in both groups. Liver function
increased to 83% in the control group and to 88% in the
PVE group. There was no correlation between volumetric
and functional recovery, confirming the postulation that
liver volume does not necessarily reflect liver function
during liver regeneration.
7
To our knowledge, there are no studies that compared
postoperative liver volume increase and functional in-
crease after partial liver resection in patients with and
without prior PVE. Although there could have been a
difference in initial regenerative response following liver
resection, our results show comparable restoration rates of
liver volume 3 months after (extended) hemihepatectomy
in both groups.
Most data on the process of hepatocyte regeneration
have been obtained from animal or in vitro studies. The
time course of liver regeneration after PVE and after partial
liver resection appears to be similar as has been shown in a
rat model.
21 Although various mediators and pathways
involved in liver regeneration have been described, the
initial trigger of the entire process remains elusive.
22–25 The
instant change in portal blood flow after partial liver
resection is believed to be a trigger for liver regeneration.
Experimental studies have shown decreased posthepatec-
tomy liver regeneration in rats receiving a portacaval
shunt.
26,27 When performing PVE prior to surgery, the
change in portal blood flow is negligible in case of a
standard right hemihepatectomy and less profound in case
of an extended right hemihepatectomy because the portal
blood had already been diverted to the left portal vein at the
time of PVE. Our study shows that the liver regenerates up
to 80% of its original total liver volume 3 months after
major liver resection, in spite of prior PVE.
One might speculate that instead of the change in
portal blood flow, the change in arterial blood flow after
hepatic resection induces liver regeneration. A study in
rats showed that ligation of the hepatic artery alone did
not affect liver regeneration.
28 However, it is questionable
whether the rat model is an appropriate surrogate model
for studying the effects of altered hepatic arterial blood
flow on liver regeneration or function. It is possible that
the hypertrophy response of the remnant liver is slower
after prior PVE in the first weeks after liver resection, but
this ultimately did not result in dissimilar liver volumes
after 3 months.
Conclusion
PVE does not hamper the regenerative capacity of the FRL
after partial liver resection. The remnant liver regenerates
up to approximately 80% of its initial total liver volume and
over 83% of its original total liver function 3 months after
major liver resection with or without prior PVE.
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